Role of Protein Binding in Drug Distribution and Clinical Outcomes

Drug distribution describes the reversible transfer of drugs between systemic circulation and tissues. In plasma, drugs exist in equilibrium between bound and unbound forms. 

Bound drug → Pharmacologically inactive reservoir

Free drug → Active, diffusible, and eliminable

Protein binding acts as a dynamic buffer system, stabilizing plasma drug concentration.

Plasma Proteins Involved in Drug Binding 

Plasma Protein Binding.

Mechanism of Drug Binding 

Drug binding is reversible and non-covalent, involving hydrogen bonding, ionic interactions, Van der Waals forces, and hydrophobic interactions.

Equilibrium: D (free) + P (protein) ⇌ DP (bound)

Reversible Binding of a Drug to Albumin.

Factors Affecting Protein Binding 

Drug-Related Factors 

Integrated Clinical Flow 

↓ Plasma Protein Levels → ↓ Drug Binding → ↑ Free Drug Fraction → ↑ Pharmacological Effect → ↑ Risk of Toxicity

10. Recent Advances

PBPK modeling, AI prediction, personalized dosing.

CONCLUSION

Protein binding plays a central role in drug distribution, efficacy, and safety.

REFERENCES

1. Schmidt S, Gonzalez D, Derendorf H. Significance of protein binding in pharmacokinetics and pharmacodynamics. J Pharm Sci. 2010.
2. Ye M, Nagar S, Korzekwa K. PBPK model for highly protein-bound drugs. Biopharm Drug Dispos. 2016.
3. Bowman CM, Benet LZ. Protein binding and uptake. Eur J Pharm Sci. 2018.
4. Mehvar R. Role of protein binding in pharmacokinetics. Am J Pharm Educ. 2005.
5. Wanat K. Protein binding in drug transport. Mol Biol Rep. 2020.
6. du Souich P et al. Plasma protein binding and response. Clin Pharmacokinet. 1993.
7. Reidenberg MM. Drug binding in renal failure. Clin Pharmacokinet. 1976.
8. Zhivkova ZD. Protein binding relationships. J Pharm Pharm Sci.
9. Xiang J et al. Glytrexate pharmacokinetics. Front Pharmacol. 2022.
10. Goodman & Gilman’s Pharmacological Basis of Therapeutics.
11. Rang & Dale’s Pharmacology.
12. Katzung BG. Basic and Clinical Pharmacology.
13. Rowland M, Tozer TN. Clinical Pharmacokinetics.
14. Otagiri M. Drug–protein interactions. Drug Metab Pharmacokinet.
15. Kremer JM et al. α1-acid glycoprotein binding.
16. Hochepied T et al. α1-acid glycoprotein in inflammation.